Last Andrew J. — SEC Form 4 filings
SEC reporting owner CIK 1485088. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-12 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 3,000 shares, $989,815 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 3,000 shares @ $329.94 ($989,815) in BIO-RAD LABORATORIES, INC., filed 2024-09-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BIO-RAD LABORATORIES, INC. | EVP, Chief Operating Officer | 4 | — | 1 leg · 3,000 sh · $989,815 | 18 |
| Insight Molecular Diagnostics Inc. (IMDX) | Director | 4 | — | — | 4 |
Form 4 filings — Last Andrew J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Tax withholding (F): 7,700 @ $5.69 | EDGAR |
| 2026-06-15 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Grant/award (A): 26,943 @ $0 | EDGAR |
| 2025-07-03 | 4 | Insight Molecular Diagnostics Inc. (IMDX) | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2024-09-10 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 3,000 @ $299.24 · Sale (S): 3,000 @ $329.94 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 1,252 @ $0 · Tax withholding (F): 635 @ $337.32 · Option exercise (M): 867 @ $0 · Tax withholding (F): 440 @ $337.32 · Option exercise (M): 633 @ $0 · Tax withholding (F): 321 @ $337.32 · +6 more | EDGAR |
| 2024-07-03 | 4 | Oncocyte Corp (OCX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-04-30 | 4 | BIO-RAD LABORATORIES, INC. | Option exercise (M): 1,000 @ $0 · Tax withholding (F): 357 @ $277.11 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | BIO-RAD LABORATORIES, INC. | Grant/award (A): 5,891 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1485088 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →